Citigroup Cuts DR Horton Price Target to $150 From $160
Citigroup maintained a Neutral rating on DR Horton while lowering its price target to $150 per share from $160.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Citigroup maintained a Neutral rating on DR Horton while lowering its price target to $150 per share from $160.